A clinical trial to study the effect of Triphala churna with Madhu in Timir with special reference to Simple Myopia

A randomized controlled clinical trial to study the effect of triphala churna with madhu in timir with special reference to simple myopia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072268

Enrollment

Registered

2024-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age group between 18-30 years with the clinical symptoms of prathama patalgata timira (simple myopia) 2. Patients having -0.25 D to -3.00 D Spherical power with normal Fundoscopic findings

Exclusion criteria

Exclusion criteria: Congenital myopia, Pathological myopia, Acquired or Secondary type of myopia that occurs due to some factors or diseases i.e. post traumatic, drug induced etc. Patients who have myopia assosiated with other refractive errors such as Astigmatism. Patients who are known case of hypertension,diabetes mellitus. Patients who have active infectious diseases ie viral, fungal, bacterial conjunctivitis, trachoma, blephritis, Patients below 18 years and above 30 years Patient who have refractive index more than -3 D spherical

Design outcomes

Primary

Measure	Time frame
Reduction in signs and symptoms of timir after taking Triphala churna with madhu orallyTimepoint: 30 days	—

Secondary

Measure	Time frame
where the trial group stands in comparison with control groupTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Ashwini Raosaheb Borude

SMBT Ayurved College and Hospital

petalsayu@gmail.com9850447661

Outcome results